Wealthspire Advisors (Maryland)’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-31
Closed -$4K 2670
2018
Q4
$4K Buy
+31
New +$4.71K ﹤0.01% 1897

Other funds holding LOXO

Wealthspire Advisors (Maryland)'s LOXO Position: Q1 2019 in Review

Wealthspire Advisors (Maryland) sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 31 shares — an estimated $4K sold.

Wealthspire Advisors (Maryland) first reported a position in LOXO in Q4 2018 and held it in 1 quarter. The position peaked at $4K in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 31 Loxo Oncology, Inc shares in Q1 2019, an estimated $4K.
  • Wealthspire Advisors (Maryland) first reported a position in Loxo Oncology, Inc in Q4 2018 and held it in 1 quarter.
  • Wealthspire Advisors (Maryland)'s Loxo Oncology, Inc position peaked at $4K in Q4 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q1 2019, filed 13 May 2019.